RRAS: A key regulator and an important prognostic biomarker in biliary atresia

doi:10.3748/wjg.v17.i6.796

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3738)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-6) series.

Item

Count

PDF

402

HTML

3042

Figures (1-5)

142

Tables (1-6)

152

Sum=3738

Feb 14, 2011 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 14, 2011; 17(6): 796-803
Published online Feb 14, 2011. doi: 10.3748/wjg.v17.i6.796

Full Size Figure Download Figure

Figure 4 Reverse-transcription polymerase chain reaction showing significantly higher relative expression levels of RRAS, POMC, SLC26A6 and STX3 genes in biliary atresia patients (n = 40) than in neonatal cholestasis patients (n = 14). ^aP < 0.05 vs liver tissue samples from neonatal cholestasis patients.

Citation: Zhao R, Li H, Shen C, Zheng S. RRAS: A key regulator and an important prognostic biomarker in biliary atresia. World J Gastroenterol 2011; 17(6): 796-803
URL: https://www.wjgnet.com/1007-9327/full/v17/i6/796.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i6.796